| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 3.972 | 15.134 | 16.712 | 21.576 | 11.375 |
| Total Income - EUR | - | - | - | - | - | 3.972 | 15.134 | 16.778 | 21.576 | 11.375 |
| Total Expenses - EUR | - | - | - | - | - | 3.185 | 12.250 | 16.539 | 12.757 | 13.811 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 787 | 2.884 | 239 | 8.819 | -2.436 |
| Net Profit/Loss - EUR | - | - | - | - | - | 711 | 2.733 | 71 | 8.608 | -2.436 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medlor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.953 | 3.984 | 5.762 | 13.934 | 15.055 |
| Inventories | - | - | - | - | - | 1.114 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 1.101 | 12.104 | 13.554 |
| Cash | - | - | - | - | - | 839 | 3.984 | 4.661 | 1.831 | 1.501 |
| Shareholders Funds | - | - | - | - | - | 752 | 3.468 | 3.549 | 12.147 | 9.643 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.201 | 516 | 2.213 | 1.788 | 5.413 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medlor S.r.l.